ACET - アセト (Aceto Corporation) アセト

 ACETのチャート


 ACETの企業情報

symbol ACET
会社名 Aceto Corp (アセト)
分野(sector) Health Care   ヘルスケア
産業(industry) Other Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 アセト(Aceto Corporation)は完成剤形のジェネリック医薬品、栄養補助食品、医薬活性成分、農業中間体と農産物保護製品等の特殊化学製品のマーケティング・販売を行う。同社はヒューマンヘルス、医薬品原料と機能化学品という3つの事業セグメントを運営する。ヒューマンヘルス事業には、ジェネリック医薬品と栄養補助食品を含む。機能化学品事業は特殊化学品、農業保護製品を含む。   アセトは米国の医薬品原料・化学品販売会社。プラスチック原料、プラスチック用酸化防止剤、界面活性剤、潤滑油などの工業薬品のほか、医薬品、生化学品、栄養剤、医薬品中間物、農薬、有機中間物、色素などを販売する。本社はニューヨーク州ポ―トワシントン。   Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
本社所在地 4 Tri Harbor Court Port Washington NY 11050 USA
代表者氏名 William C. Kennally ウィリアム・C.・ケンナリー
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 516-627-6000
設立年月日 17319
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 315人
url www.aceto.com
nasdaq_url https://www.nasdaq.com/symbol/acet
adr_tso
EBITDA EBITDA(百万ドル) 14.06600
終値(lastsale) 2.37
時価総額(marketcap) 72965761.17
時価総額 時価総額(百万ドル) 68.65555
売上高 売上高(百万ドル) 711.35900
企業価値(EV) 企業価値(EV)(百万ドル) 282.14955
当期純利益 当期純利益(百万ドル) -304.82700
決算概要 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Aceto Corporation revenues increased 11% to $711.4M. Net loss before extraordinary items totaled $304.8M vs. income of $11.4M. Revenues reflect Human health segment increase of 19% to $374.5M Performance Chemicals segment increase of 8% to $178M United States segment increase of 11% to $535.7M Germany segment increase of 22% to $96.7M. Net loss reflects Selling.

 ACETのテクニカル分析


 ACETのニュース

   Aceto Propels Growth Strategy with Cascade Chemistry Acquisition  2021/06/02 00:00:00 BioSpace
Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced the acquisition of Eugene, Oregon-based Cascade Chemistry, manufacturer of active pharmaceutical ingredients, regulatory starting materials and advanced intermediates.
   Acetos Acquisition of a Majority Stake in Finar  2021/05/20 00:00:00 Global Legal Chronicle
DSK Legal advised Finar Limited and its promoters Girish Maheshwari, Amit Maheshwari and other selling shareholders. Aceto executed the acquisition of a majority stake in Indian []
   Pharmaceutical Intermediates Market Analysis with Global Economic Growth (2021-2027) | Top Prominent Players- Aceto, Eastar Chem, BASF, Midas Pharma, Arlife Sciences, Wintersun Chem, Ganesh Group  2021/05/19 04:55:00 Jumbo News
Global Pharmaceutical Intermediates Market size, share and CAGR Analysis 2021-2027 Pharmaceutical Intermediates Market report performs comprehensive Analysis about Global Market and tells about the market status in the forecast period. The report recognizes and analyses the growing trends along with major drivers, restraints, challenges and opportunities in the Pharmaceutical Intermediates industry. The market research report []
   Surface Oncology, Mustang Bio among top picks as BTIG turns bullish on cell and gene therapy space  2021/05/18 14:50:43 Seeking Alpha
   Adicet Bio EPS misses by $0.31  2021/05/17 11:31:08 Seeking Alpha
   Benzocaine Market Analysis Report, Size, Share, key growth drivers, challenges, opportunity assessment, Global industry by Product type, Segment and Regional Forecast to 2027 | TCI Chemicals (India) Pvt. Ltd, Merck KGaA, ACETO Corporation, Alfa Aesar  2020/11/20 03:04:34 OpenPR
The Global Benzocaine Market report provides a holistic evaluation of the market for the forecast period (2018–2026). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the
   Former CFO of Long Island Pharmaceutical Company Pleads Guilty to Insider Trading  2020/11/09 19:36:30 US Department of Justice
Earlier today, at the federal courthouse in Central Islip, Douglas Roth, the former Chief Financial Officer (CFO) of Aceto Corporation (Aceto), a pharmaceutical company based in Port Washington, New York, pleaded guilty to securities fraud for insider trading.
   SEC accuses former Aceto CFO of insider trading after retirement  2020/11/05 20:32:08 Reuters
The U.S. Securities and Exchange Commission sued the former chief financial officer of Aceto Corp in Brooklyn federal court on Thursday alleging he learned inside information about the now-defunct generic drug company's precarious financial condition before his 2018 retirement…

 関連キーワード  (医薬品 米国株 アセト ACET Aceto Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)